Abstract:Objectives Nuclear factor-κB (NF-κB) family are critical regulators in immunity, stress responses, apoptosis and differentiation, however, tissue NF-κB metabolism and their relevance to methylation status remain unknown. Methods We examined gene expression profiles of 5 NF-κB transcription factors, 6 inhibitory IκB proteins (I-κB), 3 IκB kinase (IKK) complex and 24 pathway components in NF-κB signalling pathway. Data-base mining of NF-κB family members and conponnets mRNA expressions are accomplished by querying GEO DataSets profiles under inflammation cytokine stimuli, hypomethylation status, and homocysteine treat. We analysed correlations between gene expression, S-adenosylhomocysteine (SAH), and S-adenosylmethion ine (SAM) levels, and SAM/SAH ratios in 7 mouse tissues. Results Our results showed that (1) NF-κB family members and pathway components have different expression levels in different tissues, and high expression in mouse, but inactive in human in normal condition; (2) Vascular system has lower response to NF-κB activity; (3) Tissues can be divided into 3 tiers according to essential molecular of NF-κB canonical and non-canonical pathway expression level in normal condition; (4) Canonical pathway is activated immediately after inflammatory cytokine TNF-α, IL-1 stimuli, but non-canonical pathway is up-regulated until 4 h treatment; (5) Lymphotoxin β/LIGHT has no effect on NF-κB family members and components expressions at 4 h; (6) Sca1+ subset endothelial progenitor cells has lower NF-κB family members and components expressions level than Sca1- subset endothelial progenitor cells; (7) Most of NF-κB family members and components expressions are down-regulated by hypomethylation status; (8) Most of NF-κB family members and components expressions are down-regulated by acute homocystein treat in different cell type. Conclusions These new results provide an insight on the roles of NF-κB family members and components in tissues and cross talk between canonical and non-canonical pathway in different cell type, and its relevance to methylation. Our study is the first to make a model of specific tissue gene expression profiles of NF-κB and regulation of tissue methylation.

Identification of Novel Pretranslational Regulatory Mechanisms for NF-κB Activation.

Abstract 568: Identification of Novel Pre-translational Regulatory Mechanisms for NF-?B Activation

GW24-e3853 Identification of Novel Pre-translational Regulatory Mechanisms for NF-kB Activation

CROSS TALK OF NF-κB CANONICAL AND NON-CANONICAL PATHWAY IN HUMAN AND MOUSE TISSUES

A Database And Functional Annotation Of Nf-Kappa B Target Genes

NF-B signaling in inflammation and cancer

NF‐κB signaling in inflammation and cancer

Role and Mechanisms of the NF-ĸB Signaling Pathway in Various Developmental Processes

Nf-Kappa B and Its Regulation on the Immune System

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System

Nf-Kappa B Signaling in Inflammation

Signaling via the NFκB system

The Functional Analysis of MicroRNAs Involved in NF-κB Signaling.

NF-κB in biology and targeted therapy: new insights and translational implications

Nuclear Factor Kappa B Signaling Complexes in Acute Inflammation

Targeting NF-B pathway for the therapy of diseases: mechanism and clinical study

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

NF-κB signaling in inflammation

Activation of NF-κ B Signalling Pathway by Inflammatory Regulators and Associated Drug Discovering

Transcriptional and Epigenetic Regulation of Immune Tolerance: Roles of the NF-κB Family Members